|
|
|
 |
| Home | About Us | Products/Price List/Order | Contact | |
|
|
|
enhancing herb of all herbs native to the Amazon. In her article titled Herbal Treasures from the Amazon Part I, she mentions that preliminary studies suggest that the herb has an ability to stop viral infections in early stages, help patients who are chemically sensitive, fight infections and decrease the visible size of some skin tumours and cysts within a few weeks. Dr Schwontkowsky also reports that U. tomentosa has been linked with the remission of brain tumours as well as providing relief from the side effects of chemotherapy.
Primal Nature’s director, Ronald Prochnik, collects medicinal plants in the peruvian rainforest.
|
|
Chief complaint: severe pain in back, neck & head; insomnia; abdominal pain, no hunger and chronic fatigue.
Subjective: patient came in with severe pain in back, neck and head radiating from back of neck over head to eyes. He had had this for two years since he was diagnosed after much effort with shingles of the spinal chord and accompanying meningitis. He took advil continuously and slept only 1-3 hours a night. His work was as a counselor mediating often in violent family situations; extremely stressful. He had extreme pain in the abdomen with very little appetite and thirst.
Assessment: The patient had never recovered from his shingles (herpes zoster). He took medication which caused an ulcer in his stomach, preventing him from getting nutrients that might aloow him to heal. From viral insult, stress, lack of nutrients, lack of sleep from pain; he developed the imbalance which caused chronic fatigue.
Treatment: The patient was treated with acupuncture for pain. Malic acid for the fibromalgya, and Cat's Claw, 3,000mg, for viral insult and to restore his gut to order. He was asked to rest and then begin gentle exercise.
Recovery: Recovery was very quick. He began sleeping immediately (during acupuncture) and within 24 hours, he was able to eat more and not have the stomach pains which he usually experienced. His energy seemed much better (instead of 1, on scale of 1-10, it jumped to 5 or better). His headaches occurred only with severe stress. He eventually decided to change careers. Now after 3 months, he continues to take Cat's Claw when he has gastric distress from stress, but otherwise is one of the healthiest people I know; just recently marrying!
Subjective: This patient came requesting Cat's Claw for her treatment during radiation. Her tumour was already excised and lymphs were negative.
Treatment: Her treatments consisted of Cat's Claw, 3,000 mg a day and weekly acupuncture.
Result: During 9 weeks of radiation treatments, she had no hair loss, energy maintained stable. She also had no loss of appetite or nausea. She received minor local burns on the skin in area which healed very quickly. Her physicians were amazed by her recovery. She feels better now than before the cancer. We will assess her continuously for the next 10 years.
Dr Ambrose has also reported seeing significant improvements in patients suffering from Crohns disease, ulcers, asthma, arthritis, iritis,dysbiosis and chronic fatigue syndrome. One patient, a woman who had been taking sulfasalazine (a sulfa drug with numerous side effects) to treat a bleeding ulcerative condition associated with Crohns, was able to quit the drug after a few weeks using Cat's Claw. Her bleeding condition seems to have cleared up and she is reported to be experiencing much higher levels of energy.
Dr Ambrose also mentioned that she has been able to eliminate the use of many Chinese herbs because U. tomentosa, in many instances, seems to enhance overall immunity while increasing stamina and energy in patients who suffer from physical and mental exhaustion due to an overactive or stressful lifestyle.
Chief complaint: Began with sharp constant pain in left leg. Pain progressed to limiting mobility.
History & Progression: Sought medical advice; diagnosed hardening of the arteries. Physician recommended angioplasty to open blocked artery. Patient declined after reading from library sources and recent research papers alluding to limited benefits.
Patient consulted a Naturopathic physician; he recommended hydrogen peroxide chelation. She began a series of treatments. She was taking large amounts of balanced mineral supplements in conjunction with chelation therapy. At initial treatments, leg appeared to improve, but after 5th treatment, the pain in the leg was as severe as when she began. She decided she just needed to persevere until the treatments had time to work. Her overall health began to fail; her vitality was greatly reduced. She had several acute conditions in close proximity to each other. After spending over fifteen hundred dollars, she stopped chelation therapy.
Pain was so severe now that she acquired a handicap sticker for her car; she could not walk any distance, normal household shopping was too painful to perform. Pain had increased to being constant.
Treatment: She consulted with our office. Cat's Claw was prescribed beginning with 3 - 350mg capsules per day for the first 14 days, increasing to 6 - 350mg capsules thereafter.
Recovery: After 30 days she was able to resume household shopping chores. She continued taking Cat's Claw and a liquid mineral supplement was then added to improve her mineral depletion after chelation. Within the following 60 days the pain in the leg was gone, her vitality had returned. She was able to resume all activities. After 16 months, she continues to take Cat's Claw at 2 - 350mg per day to maintain open arteries. She experiences no pain and gives the herb Cat's Claw the entire credit for saving her from surgery.
Chief Complaint: He has been plagued by a recurring boil on nape of neck beginning in high school.
Assessment: This recurrence is at the rate of every 4 - 6 weeks and during the last four years has never subsided completely between acute periods.
Treatment: Began taking Cat's Claw at 6 - 350mg capsules per day.
Recovery: Within 3 weeks, the boil had disappeared. The following two weeks, all traces of this 45 year old boil had disappeared. He continues to take Cat's Claw at the rate of 6 per day as he has experienced its blood purifying properties. He has since began his mother, age 80 on Cat's Claw and she has seen an improvement in chronic pain from arthritis.
Dr Clemens has also reported witnessing the herb's ability to expel parasites from the bowel, and greatly reduce the side effects of both radiation and chemotherapy in cancer patients.
Patients in Europe have been treated with Cat's Claw extract since the introduction into Germany and Austria of Cat's Claw extract products in 1984 in accordance with Section 12/2 of the Austrian Pharmaceuticals Law and Section 73/3 of the German Pharmaceutical's Law.
Cat's Claw extract is indicated in Europe as a monotherapeutic agent or in combination with other therapies for:
- diseases which are primarily related to infiltrative processes or latent chronic infection
- diseases which are primarily related to a malfunctioning of the immune system
- as an adjuvant to the classical therapy of tumours and as in the after treatment of tumours
- disease which can be traced back to viral infections
Infections with Herpex Simplex and Varicella ZosterIn 1989, Cat's Claw extract was used to treat a group of 37 patients suffering from florid Herpes infections; 17 of the patients had florid Herpes simplex, while 20 of the patients had infections with Varicella zoster.
Until the lesions were healed, patients were clinically assessed daily by the treating practitioner and the extract was also administered to them on a daily basis.
Pain had disappeared in all of the 17 patients suffering from Herpex simplex one week after the beginning of the therapy and the herpetic lesions had completely healed on the 17th day of the therapy.
16 of the 20 patients suffering from Varicella zoster were treated with a lower dose 1 x day of Cat's Claw extract, while 4 patients were given a much higher dose, at two-hourly intervals.
All of the patients in the group of 16, except for one patient, were subjectively free of symptoms 7 days after beginning treatment. The herpetic lesions had completely healed in 15 of the patients after 13 days of starting the therapy. One of the patients discontinued treatment without effect after 13 days.
Pains were greatly reduced in all of the 4 patients treated with the higher dose after the first day of treatment and three days after beginning treatment all four patients were pain-free.
Before starting the therapy, the herpetic lesions in 3 of these 4 patients were between 4 and 20 cm in diameter and were at the pustulous stage. One of these patients initially had pustules which could be detected under the magnifying glass, and suffered severe pain. One day after starting the Cat's Claw extract treatment, the lesions in three of the patients were commencing to dry out and in one of the patients the lesions had reduced its size. On the 2nd day the lesions in the 3 patients were dry and forming scabs and by the 5th day the scabs had disappeared, and the area of skin concerened looked different from normal only because of hyperaemia.
During the nine years between 1983 and 1992, 56 patients with tumour diseases took part in a trial therapy with Cat's Claw extract. 22 of these patients provided information on the progress of their condition while they were undergoing therapy with Uncaria tomentosa extract.
The patients were given Cat's Claw extract in addition to operative, chemoterapy and radiation treatment.
Soon after starting the therapy with Cat's Claw, all patients showed increased vitality and mobility, while their side effects from chemotherapy and radiation treatment diminished.
Patients suffering from very advanced tumour diseases achieved at least an arrest of the growth or a partial remission for several months. Patients still at early stages of the disease achieved full remissions which lasted up to 10 years.
Patients and Methods: from 1983 to 1985 six patients suffering from rheumatoid arthritis participated in a trial therapy with Uncaria tomentosa extract. After an average period of 9.2 years all of these patients reported regarding the long term effects of the treatment.
Each patient was invited individually for a personal discussion on the progress of her illness since the termination of the two-year therapy with Cat's Claw 8 years earlier. Also, two of the patients had agreed to submit to regular blood tests during the entire observation period.
Medication: During the first controlled treatment cycle the patients were given 60ml decoction of Cat's Claw tea every day, this being equivalent to 3mg alkaloids daily. Four of the six patients subsequently continued with the test preparation therapy themselves using Cat's Claw extract capsules.
Results: At the outset of the therapy with the Cat's Claw preparation 5 of the patients were given therapy with Diclofenac, each of the patients was additionally given a course of aurotherapy and treatment with chloroquine, and one patient suffering from juvenile arthritis was given a high dosage level maintenance treatment with cortisone.
All six patients suffered from rheumatoid arthritis of an episodic-progressive character with repeated generalised episodes of the disease having occured in the past. The clinical case-taking at the time of beginning of the therapy corresponded to a functional stage equivalent to Steinbrocker II/III in 4 of the patients and to a functional stage equivalent to Steinbrocker I/II in two of the patients.
Clinical progress: All patients continued with the above described therapies on commencing with therapy with Cat's Claw, which was given concurrently.
During the first three months of therapy with Cat's Claw three of the patients complained of increased pain in the afflicted joint whilst the other three experienced a lessening of such pain already during the first month of treatment with Cat's Claw.
Six months after the start of the Cat's Claw therapy all patients reported a lessening of their pains as well as of joint stiffness, and a reduction in the inflammatory symptoms in the joints concerned.
After 12 months 3 of the patients were largely free of pain whilst the other 3, although still feeling reduced pain, did experience some pain-free intervals. After 18 months all of the patients were most pain free.
The gold salts and chloroquine therapies mentioned above were continued. The therapy with Diclofenac was replaced by sporadic doses as and when required. the cortisone therapy involving a daily dosage of 70 mg was replaced by a maintenance therapy with alternating dosage levels of 2 and 4 mg/day.
The treatment with Cat's Claw was continued for 24 months.
Laboratory findings: One of the two regularly examined patients was seropositive (rheumatism finding) before beginning therapy, the other one was seronegative. Both had very high blood sedimentation rates with one-hour values sometimes in excess of 100mm.
Long-term effects: The clinical health of the 2 patients at the Steinbrocker I/II functional stage remained good for the next six years on average (5 - 7 years) without the need for further therapy. In the case of the other 4 patients i.e. those at the Steinbrocker II/III stage, good clinical health was maintained for 1.7 years on average (1 - 2 years).
Therapy with Cat's Claw was resumed subsequently to the new reocurrence of clinical problems. The therapeutic effects followed the pattern established in the first treatment.
All six patients reported it to be remarkable that, in contrast to progress of the disease prior to therapy with Cat's Claw, there had been no generalised episodic occurences throughout the entire observation period and this from the first time Cat's Claw was administered onwards.
Side effects: Throughout the entire observation period lasting 10 years no side effects of the therapy with Cat's Claw were observed in any of the patients treated.
Patients and Methods: From 1983 to 1992 seven patients suffering from allergic respiratory diseases participated in a trial therapy with Cat's Claw. The average observation period per patient was 4 (1 - 10) years.
Medication: 4 of the 7 patients were treated with a daily dosage comprising 60ml decoction of Cat's Claw tea, equivalent to 3mg alkaloids per day. The other 3 patients were treated with Cat's Claw capsules, equivalent to 60mg of extract per day.
Results: Clinical case report for the patients before the beginning of therapy: At the time of first submitting to therapy with Cat's Claw one of the patients had been suffering from a pronounced allergic-atopic symptom syndrome condition with allergic rhinitis, conjuntivitis, bronchial asthma, and severe neurodermitis since four years previous.
Three of the female had been suffering anamnestically for years from bronchial asthma with complicating chronic bronchitis.
The other three male patients suffered from seasonal allergic rhinitis - which in two of the cases was coupled with asthmatic complaints.
Two of the patients were given treatment with cortisone prior to starting therapy with Cat's Claw, and all the patients were given a symptomatic therapy with antihistamines whenever the need arose.
Clinical progress: The above described therapies were continued with all patients even after treatments with Cat's Claw had commenced; therapy with Cat's Claw was concurrent.
After three months of treatment with Cat's Claw the patients were already largely free of rhinits symptoms, although the asthmatic complaints had not yet shown any sign of real improvement, nor had the appearance of the skin of the patient with neurodermitis.
Twelve months after the beginning of therapy all 4 patients with the already described permanent discomforts due to rhinitis, bronchial asthma and neurodermitis were largely free of their discomfort. The discomfort of chronic bronchitis could not be influenced by therapy with Cat's Claw. 2 of the 3 patients suffering from seasonal bouts showed greatly reduced allergic symptoms when the next allergy season came.
Long-term effects: long term observations (i.e. over a period of 10 years) are available for two of the patients suffering from non-seasonal bronchial asthma. During this period both these patients underwent several prophylactic therapies with Cat's Claw. Both these patients have been free of discomfort since the first therapy with the test preparation.
Side effects: throughout the entire 10 year observation period none of the 7 patients treated reported any side effects attributable to therapy with Cat's Claw.
Patients and methods: The following is an account of controlled progress observations over a continuous period of 4 months with 7 patients suffering from stomach or duodenal ulcers or gastritis.
Medication: Cat's Claw tea at the daily dosage of 1.5g as decoction in 120ml water to be taken in the mornings on an empty stomach.
Results: Clinical case-taking before starting the therapy: Two female and three male patients with Ulcus ventriculi and/or Ulcus duodeni. Two male patients with relapsed gastritis. Six of the patients have been suffering for years with recurring gastrointestinal ailments.
Clinical progress: All 5 patients with ulcer anamnesis were freed of all discomfort after 10 days on average (6 - 14 days), and there were no more nightly pains. Therapy with antiacidica was discontinued in all five cases.
Both patients with relapsed gastritis were freed of discomfort after 3 days on average (2 - 4 days). There was no reoccurence of pains; the patient whose symptoms prior to Cat's Claw therapy had included diarrhoea reported a regression of that symptom and the patient whose symptoms prior to the Cat's Claw therapy had included episodes of fever and pseudostenocardia reported a cessation of these symptoms. These two patients also had no further need for therapy with antiacidica.
This state of being free of any discomfort lasted with continuation of Cat's Claw therapy over three months and persisted in all patients throughout a further month of observation after therapy had been terminated.
No haematological side effects have been identified during monotherapy with Cat's Claw Extract. However, when Cat's Claw Extract drops were taken concurrently with large dose chemotherapy, cases were sometimes observed where theere was a sharp fall in trhe erythrocytes. By contrast, the use of Cat's Claw extract drops on an alternating basis (every 2nd to 6th day, and up to within 2 days before the beginning of the chemotherapy cure) is seen to afford protection against chemotherapy-induced side effects. HIV-infected patients with AIDS may show a slight decrease of erythrocytes under the influence of the therapy with Cat's Claw extract.
Temporary constipation lasting for up to one or two weeks may sometimes occur in patients when first taking Cat's Claw Tea. However, this problem can be managed with laxatives.
So far no hepatic function disturbances have been observed in connection with the taking of Cat's Claw.
So far no renal disfunction has been observed in connection with the taking of Cat's Claw .
So far it has not been established that the taking of Cat's Claw has any influence on the cardiovascular system.
One HIV-infected patient with acne papulosa on his shoulders previous to a therapy with Cat's Claw capsules showed an aggravation of acne symtoms associated with the therapy with Cat's Claw capsules.
Patients with cancer or HIV-infection may show an increase of uric acid as a result of enhanced activity of the celular immune system dependent on augmented lysis of tumour cells or viral infected cells when taking Cat's Claw extract.
So far is has not been established that the taking of Cat's Claw has any influence on either the central or the peripheral nervous system.
So far neither the oral or topical appliccation of cat's Claw has provoked any allergic reactions.
Since Cat's Claw preparations are known to have strong immuno-modifying properties, we advise against taking Cat's Claw at the same time as parenteral applications of preparations based on foreign proteins such as passive vaccinations, foreign protein therapies (thymus), hormone therapies with animal proteo or peptide hormones (insulin), or blood clotting factor since the occurence of a serum sickness is conceivable under such circumstances. However, no such interactions have so far been observed in practice.
In cases where Cat's Claw extracts and large dose chemotherapy were taken at the same time a more prononuced fall in the erythrocytes was sometimes observed. This may be attributable to the faster elimination of damaged cells from the circulatory system.
By interrupting the oral application of Cat's Claw two days prior to the chemotherapy cure and resuming again two days after completion of the chemotherapy cure this effect can be avoided.
